Healthcare provider profile · identity verified

Scott R. Mann, M.D.

Family Practice · YORK, PA · NPI 1073585840

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	911	245
Lisinopril	Lisinopril	536	137
Levothyroxine Sodium	Levothyroxine Sodium	439	103
Metoprolol Succinate	Metoprolol Succinate	354	94
Losartan Potassium	Losartan Potassium	324	86
Amlodipine Besylate	Amlodipine Besylate	320	92
Hydrochlorothiazide	Hydrochlorothiazide	298	90
Omeprazole	Omeprazole	269	67
Tamsulosin Hcl	Tamsulosin Hcl	232	65
Escitalopram Oxalate	Escitalopram Oxalate	226	57
Rosuvastatin Calcium	Rosuvastatin Calcium	205	54
Metformin Hcl Er	Metformin Hcl	203	57
Pantoprazole Sodium	Pantoprazole Sodium	199	52
Meloxicam	Meloxicam	191	75
Furosemide	Furosemide	169	43
Lorazepam	Lorazepam	167	38
Eliquis	Apixaban	165	35
Simvastatin	Simvastatin	145	36
Atenolol	Atenolol	140	36
Gabapentin	Gabapentin	139	39
Metformin Hcl	Metformin Hcl	123	34
Sertraline Hcl	Sertraline Hcl	121	28
Montelukast Sodium	Montelukast Sodium	110	29
Spironolactone	Spironolactone	109	28
Pravastatin Sodium	Pravastatin Sodium	105	28
Albuterol Sulfate Hfa	Albuterol Sulfate	104	44
Zolpidem Tartrate	Zolpidem Tartrate	103	23
Glimepiride	Glimepiride	101	30
Metoprolol Tartrate	Metoprolol Tartrate	94	30
Clopidogrel	Clopidogrel Bisulfate	90	22
Famotidine	Famotidine	89	28
Fluticasone Propionate	Fluticasone Propionate	89	34
Ozempic	Semaglutide	86	13
Duloxetine Hcl	Duloxetine Hcl	85	20
Venlafaxine Hcl Er	Venlafaxine Hcl	81	16
Tramadol Hcl	Tramadol Hcl	80	18
Finasteride	Finasteride	77	21
Alprazolam	Alprazolam	75	21
Ezetimibe	Ezetimibe	75	24
Alendronate Sodium	Alendronate Sodium	73	23
Mirtazapine	Mirtazapine	69	22
Allopurinol	Allopurinol	67	21
Celecoxib	Celecoxib	67	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	13
Glipizide	Glipizide	62	18
Pregabalin	Pregabalin	60	13
Trazodone Hcl	Trazodone Hcl	57	18
Donepezil Hcl	Donepezil Hcl	54	12
Jardiance	Empagliflozin	54	15
Xarelto	Rivaroxaban	54	suppressed
Clonazepam	Clonazepam	53	12
Pioglitazone Hcl	Pioglitazone Hcl	52	14
Amitriptyline Hcl	Amitriptyline Hcl	51	14
Bupropion Xl	Bupropion Hcl	51	14
Azithromycin	Azithromycin	50	44
Prednisone	Prednisone	49	40
Carvedilol	Carvedilol	48	13
Synthroid	Levothyroxine Sodium	48	13
Oxycodone Hcl	Oxycodone Hcl	46	14
Citalopram Hbr	Citalopram Hydrobromide	43	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	43	35
Hydralazine Hcl	Hydralazine Hcl	42	15
Tizanidine Hcl	Tizanidine Hcl	42	25
Buspirone Hcl	Buspirone Hcl	41	suppressed
Lovastatin	Lovastatin	41	suppressed
Propranolol Hcl	Propranolol Hcl	37	suppressed
Valsartan	Valsartan	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	17
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Potassium Chloride	Potassium Chloride	31	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Mounjaro	Tirzepatide	26	suppressed
Fluconazole	Fluconazole	25	12
Solifenacin Succinate	Solifenacin Succinate	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	23
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	12
Glipizide Er	Glipizide	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Cephalexin	Cephalexin	20	12
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Baclofen	Baclofen	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Levofloxacin	Levofloxacin	19	15
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Trimethoprim	Trimethoprim	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Nitroglycerin	Nitroglycerin	18	13
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Amoxicillin	Amoxicillin	17	16
Aripiprazole	Aripiprazole	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Carisoprodol	Carisoprodol	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Nystatin	Nystatin	16	11
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Ramipril	Ramipril	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Torsemide	Torsemide	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Estradiol	Estradiol	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Topiramate	Topiramate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Clonidine Hcl	Clonidine Hcl	12	suppressed
Eplerenone	Eplerenone	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Naproxen	Naproxen	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Digoxin	Digoxin	11	suppressed
Invokana	Canagliflozin	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error